THE MODERN MANAGEMENT OF PARKINSONS-DISEASE

被引：13

作者：

QUINN, N

机构：

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1990年 / 53卷 / 02期

关键词：

D O I：

10.1136/jnnp.53.2.93

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：93 / 95

页数：3

共 30 条

[1] INCREASED LIFE EXPECTANCY RESULTING FROM ADDITION OF L-DEPRENYL TO MADOPAR TREATMENT IN PARKINSONS-DISEASE - A LONGTERM STUDY [J].

BIRKMAYER, W ;

KNOLL, J ;

RIEDERER, P ;

YOUDIM, MBH ;

HARS, V ;

MARTON, J .

JOURNAL OF NEURAL TRANSMISSION, 1985, 64 (02) :113-127

[2] POTENTIATION OF ANTI AKINETIC EFFECT AFTER L-DOPA TREATMENT BY AN INHIBITOR OF MAO-B, DEPRENIL [J].

BIRKMAYER, W ;

RIEDERER, P ;

YOUDIM, MBH ;

LINAUER, W .

JOURNAL OF NEURAL TRANSMISSION, 1975, 36 (3-4) :303-326

[3]

BIRKMAYER W, 1987, J NEURAL TRANSM-SUPP, V25, P175

[4]

CHAUDHURI KR, 1988, LANCET, V2, P1260

[5] DEPRENYL SUPPRESSES THE OXIDANT STRESS ASSOCIATED WITH INCREASED DOPAMINE TURNOVER [J].

COHEN, G ;

SPINA, MB .

ANNALS OF NEUROLOGY, 1989, 26 (05) :689-690

[6] L-DOPA METHYL-ESTER - A CANDIDATE FOR CHRONIC SYSTEMIC DELIVERY OF L-DOPA IN PARKINSONS-DISEASE [J].

COOPER, DR ;

MARREL, C ;

TESTA, B ;

VANDEWATERBEEMD, H ;

QUINN, N ;

JENNER, P ;

MARSDEN, CD .

CLINICAL NEUROPHARMACOLOGY, 1984, 7 (01) :89-98

[7]

CORSINI GU, 1979, LANCET, V1, P954

[8]

Csanda E, 1987, J Neural Transm Suppl, V25, P105

[9]

DEXTER D, 1986, LANCET, V2, P639

[10] INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE [J].

DEXTER, DT ;

WELLS, FR ;

LEES, AJ ;

AGID, F ;

AGID, Y ;

JENNER, P ;

MARSDEN, CD .

JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) :1830-1836

← 1 2 3 →